v3.20.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 295,281 $ 173,016
Accounts receivable, net 87,766 94,242
Inventories 21,627 14,405
Prepaid assets 8,300 6,327
Other current assets 6,026 2,748
Total current assets 419,000 290,738
Property and equipment (net of accumulated depreciation of $80,143 and $68,809, respectively) 83,969 64,188
Operating lease right-of-use assets 47,554 26,492
Intangible assets, net 125,821 126,640
Goodwill 210,833 198,601
Restricted cash, non-current 36,030 0
Prepaid lease asset 6,084 0
Investment in non-consolidated affiliate 13,137 0
Other assets 3,057 2,847
Total assets 945,485 709,506
Current liabilities    
Accounts payable 19,198 19,568
Accrued compensation 22,065 21,365
Accrued expenses and other liabilities 7,913 7,548
Short-term portion of financing obligations 4,458 5,432
Short-term portion of operating leases 4,496 3,381
Current secured debt 0 5,000
Pharma contract liability 3,570 1,610
Total current liabilities 61,700 63,904
Long-term liabilities    
Convertible senior notes, net 164,544 0
Long-term debt, net 1,911 3,199
Long-term portion of operating leases 44,524 24,034
Long-term portion of term loan, net 0 91,829
Other long-term liabilities 3,155 3,566
Deferred income tax liability, net 15,422 15,566
Total long-term liabilities 229,556 138,194
Total liabilities 291,256 202,098
Stockholders' equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 110,396,844 and 104,781,236 shares issued and outstanding, respectively) 110 105
Additional paid-in capital 679,235 520,278
Accumulated other comprehensive loss 43 (1,618)
Accumulated deficit (25,159) (11,357)
Total stockholders’ equity 654,229 507,408
Total liabilities and stockholders' equity $ 945,485 $ 709,506

Source